FDA Inspection 1195728 — Embolx, Inc.

Embolx, Inc. — FEI 3011660785

The FDA completed an inspection of Embolx, Inc. on Jan 19, 2023 in Sunnyvale, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 19, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Sunnyvale, CA (United States)

Citations

IDCFRDescription
232821 CFR 820.22Quality audits - auditor independence
337521 CFR 820.198(e)Records of complaint investigation
342621 CFR 820.50(a)(1)Documented evaluation
369621 CFR 820.100(b)Documentation
406021 CFR 820.20(b)(3)(i)Management representative implementing the quality system
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations

Need the full FDA record for Embolx, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.